Klein to lead GE nuclear unit
Beth Klein has been tapped to lead the nuclear medicine and PET division of GE Medical Systems, replacing Sharon Banaszewski, who has been reassigned to a position overseeing the Milwaukee company’s supplier relationships. Klein is a long-time GE
Beth Klein has been tapped to lead the nuclear medicine and PET division of GE Medical Systems, replacing Sharon Banaszewski, who has been reassigned to a position overseeing the Milwaukee companys supplier relationships. Klein is a long-time GE executive who previously was general manager of CT sales and marketing in Europe. In her new role, Klein will oversee a GE nuclear medicine program that will be greatly expanded by the acquisition of Elscints nuclear medicine division (see story, page 1).
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
